text: $CNCE also setting up for a slow stochastic and MACD reversal after a decent sell off. https://t.co/HpzJhcM6bc
time: Wed Apr 25 18:26:24 +0000 2018
text: Concert Pharmaceuticals $CNCE Downgraded by ValuEngine to “Hold” https://t.co/DYRYshglpW
time: Wed Apr 25 12:37:23 +0000 2018
text: Concert Pharmaceuticals $CNCE Lowered to “Hold” at ValuEngine https://t.co/KR0hO0UewW
time: Wed Apr 25 12:35:45 +0000 2018
text: Concert Pharma completes enrollment in mid-stage study of CTP-543 in autoimmune-related hair loss https://t.co/dKvPBk0SZB #premarket $CNCE
time: Wed Apr 25 11:56:14 +0000 2018
text: RT @odibro: $CNCE Completes Enrollment in Phase 2a Trial of CTP-543 in Alopecia Areata. Topline Phase 2a Data from the 4 mg and 8 mg Cohort…
time: Wed Apr 25 11:18:25 +0000 2018
text: @odibro &amp; $CNCE said at OpCo conference that 8mg CTP-643 equivalent to 10-12mg $INCY ruxolitinib, which has shown efficacy in aa at 10-15mg.
time: Wed Apr 25 11:10:39 +0000 2018
text: RT @odibro: $CNCE Completes Enrollment in Phase 2a Trial of CTP-543 in Alopecia Areata. Topline Phase 2a Data from the 4 mg and 8 mg Cohort…
time: Wed Apr 25 11:08:24 +0000 2018
text: $CNCE Completes Enrollment in Phase 2a Trial of CTP-543 in Alopecia Areata. Topline Phase 2a Data from the 4 mg and 8 mg Cohorts Expected in Q4 2018
time: Wed Apr 25 11:06:53 +0000 2018
text: Concert Pharmaceuticals $CNCE Stock Rating Lowered by ValuEngine https://t.co/exd3XpiCwG
time: Wed Apr 25 04:09:04 +0000 2018
text: Concert Pharmaceuticals $CNCE Stock Rating Lowered by ValuEngine https://t.co/GTj2PQqt25
time: Wed Apr 25 04:07:27 +0000 2018
text: Concert Pharmaceuticals $CNCE Given Consensus Rating of “Buy” by Analysts https://t.co/MliqlpPAWM
time: Tue Apr 24 15:05:46 +0000 2018
text: Out of $INCY at open at breakeven.  Not much to be excited about, especially with coming Jakafi competition - $CNCE
time: Tue Apr 24 15:03:34 +0000 2018
text: -$0.61 EPS Expected for Concert Pharmaceuticals $CNCE This Quarter https://t.co/L4oZMPQjVH
time: Tue Apr 24 02:00:42 +0000 2018
text: Concert Pharmaceuticals $CNCE Expected to Announce Earnings of -$0.61 Per Share https://t.co/OHce4BxXo6
time: Tue Apr 24 02:00:36 +0000 2018
text: $20,000.00 in Sales Expected for Concert Pharmaceuticals $CNCE This Quarter https://t.co/xAJlFyOThr
time: Tue Apr 24 02:00:26 +0000 2018
text: RT @JediJazz22: $IVST @innovestglobal (OTC PINK:IVST) reports $708K in first quarter revenue, current assets of $932K and that the company…
time: Mon Apr 23 12:52:57 +0000 2018
